{"title":"SGLT2 inhibitors and GLP-1 agonists are best therapeutic options after metformin to lower HbA1c","authors":"","doi":"10.1002/domnow.0010015","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":235300,"journal":{"name":"News Digital Object Group","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"News Digital Object Group","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/domnow.0010015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
